Patient Spotlight: Billy Anton Balances Management and Lifestyle with Primary Ciliary Dyskinesia Dakota Campbell Tue, 03/29/2022 - 10:02
Headshot of Billy Anton

Billy Anton is a business professional and vice chair of the PCD Foundation Board of Directors. He is also diagnosed with primary ciliary dyskinesia (PCD), an inherited condition in which mucociliary clearance of the lungs is impaired, causing recurrent infections that may lead to hearing loss, chronic cough, severe lung damage, and bronchiectasis (irreversible scarring and dilation of the bronchi). Here, Billy shares his journey with PCD, from early diagnosis to getting involved in research and patient advocacy.

Patient Spotlight: Mitchell Magyar Makes an Impact on Urea Cycle Disorder Research Dakota Campbell Thu, 12/16/2021 - 11:03
Mitchell Magyar with his mother and sister, wearing sunglasses and smiling
Mitchell Magyar, center, with his mother, left, and sister, right.

Mitchell Magyar is a 13-year-old who loves golf, hiking, archery, riding his bike, and playing video games with his friends. He is also diagnosed with argininosuccinic aciduria (ASA), a type of urea cycle disorder. Here, his mother Amy Magyar shares their journey with ASA, from diagnosis to getting involved with advocacy and research participation.

Patient Spotlight: Fynan Family Fueled by OI Research Dakota Campbell Tue, 11/16/2021 - 12:06
The Fynan family posing on a beach

Michelle Fynan, PhD, LMHC, is a mother of two daughters, age seven and four. She and her daughters are diagnosed with osteogenesis imperfecta (OI) type I, the mildest form of OI, which is characterized by bone fractures that often result from minor trauma. Here, Michelle shares her journey with OI, from adolescent struggles to finding her purpose as an OI activist and researcher.

Patient Spotlight: Anthony Anzell Fights Hereditary Hemorrhagic Telangiectasia with Endurance and Education Dakota Campbell Tue, 10/19/2021 - 14:05
Headshot of Anthony Anzell, PhD
Anthony Anzell, PhD

Anthony Anzell, PhD, is a postdoctoral fellow at the University of Pittsburgh studying hereditary hemorrhagic telangiectasia (HHT). He also happens to be an HHT patient. Here, Dr. Anzell shares his HHT journey, from diagnosis, to ultramarathons, to the lab.